Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 501 News Items found Breast Cancer and Tattoo-Less Radiation at MSK Tuesday, January 3, 2023 Learn how people with early stage breast cancer can receive radiation therapy without the need for tattoos at Memorial Sloan Kettering Cancer Center. 3-D Nipple Tattoos After Breast Cancer Surgery: An MSK Specialty Thursday, September 26, 2024 Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer. In the News FDA Recommends Including Men in Breast Cancer Trials Wednesday, August 28, 2019 The recommendation comes in the form of draft guidelines open for public comment until October 2019. She Couldn’t Afford Metastatic Breast Cancer Treatment: How MSK Helped Thursday, April 10, 2025 Learn what can be done for patients like Stephanie Soto-Vega who confront financial hardships caused by cancer. Expert Breast Cancer Treatment in Harlem at MSK’s Ralph Lauren Center Thursday, October 26, 2023 See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home. Q&A Some Women with Early Breast Cancer May Not Need Chemotherapy, Study Says Sunday, June 3, 2018 The findings will change how women with intermediate-risk breast cancer are treated. Finding Why More People With Breast Cancer Are Choosing Lumpectomy Over Mastectomy: Kate’s Story Wednesday, July 13, 2022 An MSK study found a rise in lumpectomies and a decline in mastectomies — reversing a trend that experts say was leading to the overtreatment of breast cancer. In the Clinic Drug Reduces Recurrence Risk in Subset of Women with Breast Cancer Monday, June 5, 2017 A drug was shown to improve outcomes in women with HER2-positive early breast cancer when added to standard therapy. Always by Your Side: How MSK Helps People Facing Metastatic Breast Cancer Thursday, July 1, 2021 Learn how people facing metastatic breast cancer help each other in support groups at Memorial Sloan Kettering. In the Clinic Phase III Trial of Targeted Drug Shows Promise in Treating Metastatic Breast Cancer Sunday, June 4, 2017 Investigators found that olaparib extended progression-free survival by an average of three months in women with advanced breast cancer. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Press Releases